Breast cancer screening in childhood cancer survivors

Medical and Pediatric Oncology

Volumn 34, Issue 3, 2000, Pages 210-212

  Powers, Alexander ^a   Cox, Charles ^a   Reintgen, Douglas S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; Screening; Secondary cancer

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CANCER DIAGNOSIS; CANCER GENETICS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CHILDHOOD CANCER; PRIORITY JOURNAL; REVIEW;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASMS; PRACTICE GUIDELINES; RISK; RISK FACTORS; SURVIVORS; UNITED STATES;

EID: 0034053117     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200003)34:3<210::AID-MPO9>3.0.CO;2-M     Document Type: Review

References (26)

1. Rosenberg SA, Kaplan HS. The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1985;11:5-22.
2. Meadows AT, Baum E, Fossati-Bellani F, et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 1985;3:532-538.
3. Blatt J, Olshan A, Gula MJ, et al. Second malignancies in very-long-term survivors of childhood cancer. Am J Med 1992;93:57-60.
4. Bhatia S, Robison L, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-751.
5. Kaste S, Hudson M, Jones D, et al. Breast masses in women treated for childhood cancer. Cancer 1998;82:784-792.
6. Tinger A, Wasserman TH, Klein E, et al. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys 1997;37:865-870.
7. Hancock S, Tucker M, Hoppe R. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993;85:25-31.
8. Yahalom I, Petrek I, Biddinger P, et al. Breast cancer in patient irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 1992;10:1674-1681.
9. Smith L, Cox R, Donaldson S. Second cancers in long-term survivors of Ewing's sarcoma. Clincal Orthopedics and Related Research 1992;274:275-280.
10. Dietrich P, Henry-Amar M, Cosset J. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? Blood 1994;84:1209-1215.
11. Chung C, Bogart J, Adams J, et al. Increase risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1997;37:405-409.
12. Li FP, Corkery J, Canellos G, Neitlich HW. Breast cancer after Hodgkin's disease in two sisters. Cancer 1981;47(1):200-202.
13. Reintgen DS, Clark CA (eds). "Cancer Screening." St. Louis: Mosby, 1996.
14. Trent J, Yang JM, Emerson J, et al. Clonal chromosome abnormalities in human breast carcinomas. II Thirty-four cases with metastatic disease. Genes Chromosomes Cancer 1993;7(4):194-203.
15. Weber B, Ruthann MG, Liu E. Developing strategies for intervention and prevention in hereditary breast cancer. J Natl Cancer Inst 1995;17:99-102.
16. Radford B, Zehnbauer B. Inherited breast cancer. Surg Clin North Am 1996;76(2):205-219.
17. Kuttesch J, Wexler L, Marcus R, et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996;14:2818-2825.
18. Linet M, Nyren O, Gridley G, et al. Risk of cancer following splenectomy. Int J Cancer 1996;66:611-616.
19. Devilee P, van den Broek M, Mannens M, et al. Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood. Int J Cancer 1991;47(6):817-821.
20. Malkin D, Jolly KW, Barbier N, et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 1992;326(20):1309-1315.
21. Levine A, Mohamand J, Finlay C. The p53 tumour suppressor gene. Nature 1991;351:453-456.
22. Hartmann L, Schaid D, Woods J, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340(2):77-84.
23. Basset L, Ysrael M, Gold R, Ysrael C. Usfulness of mammography and sonography in women less than 35 years of age. Radiology 1991;180:831-835.
24. Otter W, Merchant T, Beijernick D, Koten J. Exclusion from mammographic screening of women genetically predisposed to breast cancer will probably eliminate mammographically induced breast cancer. Anticancer Res 1993;13:1113-1116.
25. Harper A, Kelly-Fry E, Noe J. Ultrasound breast imaging: the method of choice for examining the young patient. Ultrasound Med Biol 1981;7:231-237.
26. Ciatto S, Bravetti P, Bonardi R, Rosseli Del Turco M. The role of mammography in women under 30. Radiol Med (Torino) 1990; 80:676-678.